Janus kinases — JAKs — are enzymes sitting on the inside of your cells, right behind the receptors where inflammatory signals arrive. When a signal such as IL-4, IL-13 or IL-31 lands on the outside of a cell, JAK enzymes carry the message inward and tell the cell's nucleus to switch on inflammation.
Upadacitinib blocks that relay, with a preference for JAK1. Because so many different inflammatory messages route through JAK1, blocking it turns down a lot of signals at once. That is why it works on eczema faster and more broadly than a drug that neutralizes a single messenger — Dupixent, for instance, blocks two specific signals from the outside.
IL-31 is the itch signal, and it runs through JAK1. That is why itch on Rinvoq often improves within days, well before the rash looks better. For people who have not slept properly in years, that is frequently the thing they notice first.
The trade-off is the same breadth. JAK signaling is also how your immune system coordinates its response to viruses, to cancerous cells, and to infections. Damping it broadly is what produces the boxed warning.
Alcohol does not directly interact, but since liver enzymes are monitored on this drug, heavy drinking makes that harder to interpret.
This drug needs real monitoring. If your prescriber is not ordering these, ask why.
Fast — faster than anything else in eczema.
Itch often eases within 2 to 4 days. Many people say sleep is the first thing that changes.
Skin starts clearing within 2 weeks, with substantial improvement by 4 weeks and the best result around 16 weeks.
If 15 mg is not doing enough by around 8 to 12 weeks, the dose can go to 30 mg (in people under 65). If 30 mg is not working, the label says to stop rather than continue.
For psoriatic arthritis, joint symptoms usually improve within a few weeks.
That speed is the main reason people choose Rinvoq over a biologic, and it is a fair reason. It is also why some people are willing to accept the monitoring and the warnings.
Rinvoq controls eczema. It does not cure it.
It leaves your system quickly — this is a small-molecule pill, not a long-lasting antibody. That cuts both ways. If you develop a problem, the drug is gone within days. But if you stop, the eczema and the itch tend to return quickly too, often within a couple of weeks, and sometimes back to full severity within a month.
There is no evidence of a dangerous rebound in the way that stopping oral steroids can cause, but the practical return of symptoms is fast enough that people notice it sharply. Do not stop abruptly on your own if you can avoid it — plan the change with your dermatologist and have your topical routine or next drug ready.
If you restart later, it typically works again. There are no antibodies to build up against a small molecule.
If you stop because of side effects or because the risk profile does not suit you, reasonable alternatives for eczema include Dupixent, topical tacrolimus, topical steroids, and narrowband UVB phototherapy.